Ada Health, a leading clinical AI company that helps people understand their symptoms and navigate care safely and ...

Abridge, the leading enterprise-grade AI platform for clinical conversations, today announced content partnerships with NEJM Group, publisher of the New England Journal of Medicine, and the American ...

Medical learners in the 21st century spend less time with patients during training than their counterparts did in the 20th century, which decreases the knowledge and practice of bedside clinical ...

Selective JAK1 Inhibitors for Treatment of Atopic Dermatitis Review the role of the JAK/STAT pathway in atopic dermatitis, and the pharmacology of the JAK1 inhibitors upadacitinib and abrocitinib, ...

Peer-reviewed medical research, published by the New England Journal of Medicine and the JAMA Network, will be accessible ...

View the Applied Clinical Trials April 2026 issue in an interactive format. The April issue of Applied Clinical Trials delves into the priorities driving patient engagement approaches today from the ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Rising imaging demand and workforce shortages drive simulation adoption in diagnostic radiography education, enhancing ...

Cancer treatment often involves significant toxicity and interruptions to daily life. As a result, patient-reported outcomes (PROs) such as health-related quality of life (HRQoL) are an essential ...

Limbic, the leading evidence-based clinical mental health AI company, today announced the publication of a randomized, double-blind study in Nature Medicine evaluating its clinical reasoning system ...